BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8012678)

  • 1. The polycystic ovary syndrome. 1. Pathogenesis.
    White MC; Turner EI
    Br J Hosp Med; 1994 Feb 16-Mar 1; 51(4):167-74. PubMed ID: 8012678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome.
    Chihal HJ; Baudier MM
    Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirsutism and polycystic ovary syndrome.
    Givens JR; Goodman RC
    Hosp Pract (Off Ed); 1986 Oct; 21(10A):81-4, 87-9, 93-4 passim. PubMed ID: 3095345
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of polycystic ovarian disease.
    James R; Givens MD
    Acta Eur Fertil; 1979 Sep; 10(3):89-103. PubMed ID: 121017
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.
    Yao LQ; Kuang JQ; Feng YJ; Yang DZ; Li L; Xu CJ
    Fertil Steril; 2006 Mar; 85(3):805-8. PubMed ID: 16500371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
    Rossmanith WG; Keckstein J; Spatzier K; Lauritzen C
    Gynakol Rundsch; 1991; 31 Suppl 2():333-5. PubMed ID: 1790971
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polycystic ovary syndrome--a medical condition but also an important psychosocial problem.
    Eggers S; Kirchengast S
    Coll Antropol; 2001 Dec; 25(2):673-85. PubMed ID: 11811299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood and sexual function in polycystic ovary syndrome.
    Janssen OE; Hahn S; Tan S; Benson S; Elsenbruch S
    Semin Reprod Med; 2008 Jan; 26(1):45-52. PubMed ID: 18181082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin for the treatment of the polycystic ovary syndrome.
    Barbieri RL; Gargiulo AR
    Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hirsutism and androgenic menstrual cycle irregularities].
    Carol W; Wilke I
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):153-7. PubMed ID: 2058208
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of metformin as first line treatment in polycystic ovary syndrome.
    Abbas M; Gannon M
    Ir Med J; 2008 Feb; 101(2):51-3. PubMed ID: 18450250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polycystic ovary syndrome I. Clinical presentation and treatment].
    Ovesen PG; Møller N; Greisen S; Ingerslev HJ
    Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].
    Vulkov I; Georgiev Ch
    Akush Ginekol (Sofiia); 1982; 21(3):238-43. PubMed ID: 6289691
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.
    Ushiroyama T; Ikeda A; Sakai M; Hosotani T; Suzuki Y; Tsubokura S; Ueki M
    J Reprod Med; 2001 May; 46(5):451-6. PubMed ID: 11396371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.